Monitoring patients with neuromuscular disorders is crucial but doesn't always allow for a sufficiently specific approach to all aspects of the condition. However, in the event of future treatment, it is essential for clinical and research teams to have as much information as possible about the disease, particularly regarding its physical, physiological, biological, and neurological aspects.
In this context, it was consider as vital to investigate in greater depth the links between the presence of certain dystrophin isoforms in patients and their potential impacts on cognitive, neurological, and muscular function. The results of this study could serve as a reference for future research and improve the understanding and management of this disease.
All of this data will allow for a precise evaluation of the effects of a potential treatment on the progression of the disease.
Genetically confirmed diagnosis of Becker muscular dystrophy
Ambulant
Signed ICF
Individuals presenting contraindications to MRI
History of allergy to contrast product
Individuals with history of neurological diseases interfering with the study
Individuals with concomitant medical conditions that could interfere with the study outcomes
Institut de Myologie, France
Lead sponsor
Paris Brain Institute (ICM)
Collaborator
Université Paris Cité
Collaborator
Association Française contre les Myopathies (AFM), Paris
Collaborator